SCHEMBL21112929

SCHEMBL21112929

C=CCO[C@@H]1[C@@H](O)[C@H](O)[C@@H](COC(=O)c2cccc(Oc3ccccc3)c2)O[C@H]1O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
MAPT P10636 2/20 0.40
POLB P06746 1/20 0.39
AKR1C3 P42330 1/20 0.38
ADRB2 P07550 1/20 0.36
ADRB1 P08588 1/20 0.36
ADRB3 P13945 1/20 0.36
ERCC5 P28715 1/20 0.36
FEN1 P39748 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
TYMP P19971 1/20 0.35
ALDH1A1 P00352 3/20 0.35
NPC1 O15118 1/20 0.35
HK1 P19367 1/20 0.34
HK2 P52789 1/20 0.34
LGALS9 O00182 1/20 0.34
LGALS8 O00214 1/20 0.34
LGALS1 P09382 1/20 0.34
LGALS3 P17931 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21112978 0.91 SMN1; SMN2 (0.41) MEN1KMT2AMAPTALDH1A1PARP10
SCHEMBL21112930 0.87 TYMP (0.43) MEN1KMT2AMAPTPOLBAKR1C3
SCHEMBL21112880 0.85 MEN1 (0.43) MEN1KMT2AMAPTPOLBAKR1C3
SCHEMBL21113010 0.83 AKR1C3 (0.47) MEN1KMT2AMAPTPOLBAKR1C3
SCHEMBL22490901 0.80 CHRNB2 (0.44) MEN1KMT2AADRB2ADRB1ADRB3
SCHEMBL21112979 0.78 MAOB (0.45) TYMPALDH1A1TDP1
SCHEMBL21112881 0.76 TDP1 (0.48) MEN1KMT2AMAPTPOLBAKR1C3
SCHEMBL21112893 0.75 SMN1; SMN2 (0.45) MEN1KMT2AMAPTALDH1A1PARP10
SCHEMBL21112887 0.73 SMN1; SMN2 (0.50) ALDH1A1HK1HK2PARP10TDP1
SCHEMBL8657388 0.73 LGALS9 (0.50) MEN1KMT2AMAPTPOLBTYMP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210401946-A1 CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN SANOFI (FR) 2021-12-30 US disclosed
US-20210401947-A1 CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN SANOFI (FR) 2021-12-30 US disclosed
US-11090364-B2 Conjugates of a pharmaceutical agent and a moiety capable of binding to a glucose sensing protein SANOFI (FR) 2021-08-17 US disclosed
US-20190209656-A1 CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN SANOFI (FR) 2019-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11090364-B2 Conjugates of a pharmaceutical agent and a moiety capable of binding to a glucose sensing protein GPR119, SLC2A8, SLC2A4 MEN1 1610/4885KMT2A 4658/4885MAPT 3717/4885
US-20190209656-A1 CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN GPR119, SLC2A8, SLC2A4 MEN1 1610/4885KMT2A 4658/4885MAPT 3717/4885
US-20210401946-A1 CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN GPR119, SLC2A8, SLC2A4 MEN1 1610/4885KMT2A 4658/4885MAPT 3717/4885
US-20210401947-A1 CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN GPR119, SLC2A8, SLC2A4 MEN1 1610/4885KMT2A 4658/4885MAPT 3717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.